Prestige Biopharma’s Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
SINGAPORE, Prestige Biopharma, a pioneer in biopharmaceuticals, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)